<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tingyu P</submitter><funding>Intra-hospital Fund of Jiangsu Provincial Hospital of Traditional Chinese Medicine Development</funding><funding>Traditional Chinese Medicine Science and Technology Development Plan of Jiangsu Province</funding><pagination>1009-1018</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12453992</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>45(5)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To investigate the mechanisms of the effect of Shenji Guben (SJGB) decoction on chronic obstructive pulmonary disease (COPD).&lt;h4>Methods&lt;/h4>A murine model of COPD was established through lipopolysaccharide (LPS) nasal drops and passive smoke exposure, followed by evaluation of SJGB decoction efficacy &lt;i>via&lt;/i> lung function tests and histological analysis. Non-targeted liquid chromatography-mass spectrometry (LC-MS)-based metabolomics was used to explore the mechanisms of SJGB decoction in COPD.&lt;h4>Results&lt;/h4>We found that the SJGB decoction effectively reduced inflammatory cell infiltration in the airways and lungs, and improved lung function in the COPD model mice. LC-MS-based metabolomics identified 86 biomarkers in COPD models. Compared to the model group, SJGB dec</pubmed_abstract><journal>Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan</journal><pubmed_title>Liquid chromatography-mass spectrometry-based metabolomics study of the protective mechanism of Shenji Guben decoction on chronic obstructive pulmonary disease.</pubmed_title><pmcid>PMC12453992</pmcid><funding_grant_id>MS2021013</funding_grant_id><funding_grant_id>Y2021ZR11</funding_grant_id><funding_grant_id>ZD202215</funding_grant_id><pubmed_authors>Tingyu P</pubmed_authors><pubmed_authors>Jing Y</pubmed_authors><pubmed_authors>Jieyu WU</pubmed_authors><pubmed_authors>Shuang Y</pubmed_authors><pubmed_authors>Zikai S</pubmed_authors><pubmed_authors>Yu W</pubmed_authors><pubmed_authors>Hailang HE</pubmed_authors><pubmed_authors>Yue GE</pubmed_authors><pubmed_authors>Yong XU</pubmed_authors><pubmed_authors>Xianmei Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Liquid chromatography-mass spectrometry-based metabolomics study of the protective mechanism of Shenji Guben decoction on chronic obstructive pulmonary disease.</name><description>&lt;h4>Objective&lt;/h4>To investigate the mechanisms of the effect of Shenji Guben (SJGB) decoction on chronic obstructive pulmonary disease (COPD).&lt;h4>Methods&lt;/h4>A murine model of COPD was established through lipopolysaccharide (LPS) nasal drops and passive smoke exposure, followed by evaluation of SJGB decoction efficacy &lt;i>via&lt;/i> lung function tests and histological analysis. Non-targeted liquid chromatography-mass spectrometry (LC-MS)-based metabolomics was used to explore the mechanisms of SJGB decoction in COPD.&lt;h4>Results&lt;/h4>We found that the SJGB decoction effectively reduced inflammatory cell infiltration in the airways and lungs, and improved lung function in the COPD model mice. LC-MS-based metabolomics identified 86 biomarkers in COPD models. Compared to the model group, SJGB dec</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-11T05:03:47.124Z</modification><creation>2026-06-11T03:07:58.124Z</creation></dates><accession>S-EPMC12453992</accession><cross_references><pubmed>41015799</pubmed><doi>10.19852/j.cnki.jtcm.20250327.001</doi></cross_references></HashMap>